52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B

by Piratvisuth, Teerha, Komolmit, Piyawat, Tanwandee, Tawesak, Sukeepaisarnjaroen, Wattana, Chan, Henry L. Y., Pessôa, Mário G., Fassio, Eduardo, Ono, Suzane K., Bessone, Fernando, Daruich, Jorge, Zeuzem, Stefan, Cheinquer, Hugo, Pathan, Rashidkhan, Dong, Yuhong, Trylesinski, Aldo
Published 2013

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy

by Piratvisuth, Teerha, Komolmit, Piyawat, Chan, Henry LY, Tanwandee, Tawesak, Sukeepaisarnjaroen, Wattana, Pessoa, Mário G, Fassio, Eduardo, Ono, Suzane K, Bessone, Fernando, Daruich, Jorge, Zeuzem, Stefan, Manns, Michael, Uddin, Alkaz, Dong, Yuhong, Trylesinski, Aldo
Published 2016